FPH:NZXFisher & Paykel Healthcare Corporation Limited Analysis

Five Point Holdings is trading at $5.16, just below its short‑term resistance of $5.22 and comfortably above the near‑term support of $4.60. The 20‑day and 50‑day SMAs (~$4.98) sit beneath the current price, while the 200‑day SMA (~$5.52) remains above, signaling a price that is still below its long‑term average. Technical momentum is mixed: RSI at 59 suggests the stock is not yet overbought, the MACD histogram is positive and the signal line is bullish, yet the overall trend is flagged as bearish and volume is on a decreasing trajectory. On the fundamentals side, the company appears cheap – PE of 8.5 versus an industry average of 33.4 and a PB of 0.44 – but it carries a heavy debt load (debt‑to‑equity ~20x) and negative free cash flow, with operating margins in the –70% range. The recent Q1 2026 earnings release adds little clarity, as no detailed performance metrics were disclosed.
Given the combination of attractive valuation multiples, high leverage, weak cash generation, and elevated 30‑day volatility (~27%), the stock sits at a crossroads: it may offer upside if the business can stabilize cash flows, but the downside risks from financial strain and a bearish technical backdrop are significant.